The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Open accessAbstract
bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMT may also carry the risk of unintended introduction of pathogens and antibiotic-resistant microbes into the recipients.749,750”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [749]
In the citing paper
“In 2019, it was reported that in two independent clinical trials, two patients developed bacteremia with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli after receiving FMT from the same donor, and one patient died [136].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · cites this paper as [136]
In the citing paper
“This issue has become extremely timely after the transmission of an extended-spectrum b -lactamase-producing Escherichia coli strain from a stool donor to two immunocompromised recipients who developed bacteremia, with a fatal outcome in one case. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Indeed, two cases of MDR bacteria transmission with life-threatening complications have been described in patients with cirrhosis and hematological malignancy after repeated FMT. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Although FMT is generally recognized as safe, with no or limited side effects,33 unexpected toxicity has been reported, e.g., extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bacteremia in two patients who received FMT.34”
From Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy149 · Cited by 1,163
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Self-citationSchürch, A. C., Arredondo-Alonso, S., Willems, R. J. L., & Goering, R. V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.016 · Cited by 534
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344
Flagged first, then by citations
Research works printed but not linked: 1
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI supplement M100. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2019.
Cited by
Sorted by citations
Items 201–300 of 1,000
Martínez-Gili, L., McDonald, J. A. K., Liu, Z., Kao, D. H., Allegretti, J. R., Monaghan, T. M., Barker, G. F., Blanco, J. M., Williams, H. R. T., Holmes, E. C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1810531 · Cited by 65
DeLeon, O., Mocanu, M., Tan, A., Sidebottom, A. M., Koval, J., Ceccato, H. D., Kralicek, S. E., Colgan, J. J., George, M. M. S., Lake, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.014 · Cited by 64
Gut Dysbiosis and Heart Failure: Navigating the Universe Within
Madan, S., & Mehra, M. R. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1792 · Cited by 62
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 63
Kazemian, N., Ramezankhani, M., Sehgal, A., Khalid, F. M., Kalkhoran, A. H. Z., Narayan, A., Wong, G. K.-S., Kao, D., & Pakpour, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-75162-x · Cited by 61
Cheng, Y., Alhaffar, D., Saha, S., Khanna, S., Bohm, M. E., Phelps, E. L., Ghabril, M., Orman, E. S., Sagi, S. V., Rogers, N. A., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.051 · Cited by 61
Fecal microbiota transplantation: Uses, questions, and ethics
Grigoryan, Z., Shen, M. J., Twardus, S. W., Beuttler, M. M., Chen, L. A., & Bateman-House, A. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100027 · Cited by 63
Fecal Microbiota Transplantation in Dogs
Chaitman, J., & Gaschen, F. P. (2020) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2020.09.012 · Cited by 61
The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
Özdirik, B., Müller, T., Wree, A., Tacke, F., & Sigal, M. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136975 · Cited by 62
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
van Lier, Y. F., Vos, J., Blom, B., & Hazenberg, M. D. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2178805 · Cited by 66
Gut microbiome-brain-cirrhosis axis
Smith, M. L., Wade, J. B., Wolstenholme, J. T., & Bajaj, J. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000344 · Cited by 65
Roles of microbiota in response to cancer immunotherapy
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.026 · Cited by 62
The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts
Liwinski, T., Heinemann, M., & Schramm, C. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00936-6 · Cited by 60
Lu, G., Wang, W., Li, P., Wen, Q., Cui, B., & Zhang, F. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14074 · Cited by 59
Fecal microbiota transplantation as a promising treatment option for osteoporosis
Zhang, Y., Cao, M., Li, Y., Zhang, R., Wu, M., Yu, Q., & Rui, Y. (2022) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-022-01375-x · Cited by 60
Gut microbiome therapy: fecal microbiota transplantation vs live biotherapeutic products
Kim, D.-Y., Lee, S.-Y., Lee, J., Whon, T. W., Lee, J., Jeon, C. O., & Bae, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2412376 · Cited by 62
Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer
Bellone, M., Brevi, A., & Huber, S. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00064-19 · Cited by 60
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
Zhu, F., Li, C., Chu, F., Tian, X., & Zhu, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.544235 · Cited by 59
ECCO Topical Review: Refractory Inflammatory Bowel Disease
Raine, T., Verstockt, B., Kopylov, U., Κarmiris, K., Goldberg, R., Atreya, R. N., Burisch, J. M., Burke, J. P., Ellul, P., Hedin, C. R. H., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab112 · Cited by 58
Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness
Cho, N. A., Strayer, K., Dobson, B., & McDonald, B. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2351478 · Cited by 60
Dutta, D., & Lim, S. H. (2020) · Biomarker Research · doi:10.1186/s40364-020-00211-6 · Cited by 61
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis
Zhu, R., Liu, L., Zhang, G., Dong, J., Ren, Z., & Li, Z. (2023) · Bioscience Reports · doi:10.1042/bsr20222524 · Cited by 57
Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment
Lu, J., Shen, X., Li, H., & Du, J. (2024) · Exploration · doi:10.1002/exp.20230142 · Cited by 57
The Gut Microbiome in Sepsis: From Dysbiosis to Personalized Therapy
Piccioni, A., Spagnuolo, F., Candelli, M., Voza, A., Covino, M., Gasbarrini, A., & Franceschi, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206082 · Cited by 59
Microbiome-intestine cross talk during acute graft-versus-host disease
Rafei, H., & Jenq, R. R. (2020) · Blood · doi:10.1182/blood.2019000950 · Cited by 59
Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation
Gulati, A., Nicholson, M. R., Khoruts, A., & Kahn, S. A. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002167 · Cited by 55
Microbiota of the gastrointestinal tract: Friend or foe?
Senchukova, M. A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.19 · Cited by 56
The tumor microbiome in cancer progression: mechanisms and therapeutic potential
Zhang, W., Xiang, Y., Ren, H., Liu, Y., Wang, Q., Ran, M., Zhou, W., Lu, T., Zheng, X., Qiao, C., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02403-w · Cited by 57
Čierniková, S., Mego, M., & Chovanec, M. (2021) · Cancers · doi:10.3390/cancers13040782 · Cited by 55
Khanna, S., Sims, M. D., Louie, T., Fischer, M., LaPlante, K. L., Allegretti, J. R., Hasson, B. R., Fonte, A. T., McChalicher, C. W. J., Ege, D. S., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11091234 · Cited by 54
New technologies for developing phage-based tools to manipulate the human microbiome
Khan Mirzaei, M., & Deng, L. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.04.007 · Cited by 53
Negative interactions determine Clostridioides difficile growth in synthetic human gut communities
Hromada, S. E., Qian, Y., Jacobson, T. B., Clark, R. L., Watson, L., Safdar, N., Amador‐Noguez, D., & Venturelli, O. S. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110355 · Cited by 55
Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols
Hamamah, S., Gheorghita, R. E., Lobiuc, A., Sîrbu, I. O., & Covașă, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1060581 · Cited by 57
Dubberke, E. R., Orenstein, R., Khanna, S., Guthmueller, B., & Lee, C. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00744-3 · Cited by 53
Huang, M., Ji, Q., Huang, H., Wang, X., & Wang, L. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2486519 · Cited by 53
Dua, A., KUMARI, R. R., Singh, M., Kumar, R., Pradeep, S., Ojesina, A. I., & Kumar, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1618275 · Cited by 53
Hassouneh, R., & Bajaj, J. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020330 · Cited by 53
Peng, L., Yang, X., Wang, S., Chan, Y. K., Chen, Y., Yang, Z., Mao, Y., Li, L., Yang, W., & Deng, Y. (2021) · Nanoscale · doi:10.1039/d1nr07611f · Cited by 53
Self-citationRiwes, M. M., Golob, J. L., Magenau, J. M., Shan, M., Dick, G. J., Braun, T., Schmidt, T. M., Pawarode, A., Anand, S. M., Ghosh, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02587-y · Cited by 52
Ponce, D. M., Alousi, A. M., Nakamura, R., Slingerland, J. B., Calafiore, M., Sandhu, K., Barker, J. N., Devlin, S. M., Shia, J., Giralt, S., et al. (2022) · Blood · doi:10.1182/blood.2021015111 · Cited by 52
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 51
The use of fecal microbiota transplant in sepsis
Keskey, R. C., Cone, J., DeFazio, J. R., & Alverdy, J. C. (2020) · Translational research · doi:10.1016/j.trsl.2020.07.002 · Cited by 52
Rode, A. A., Chehri, M., Krogsgaard, L. R., Heno, K. K., Svendsen, A. T., Ribberholt, I., Helms, M., Engberg, J., Schønning, K., Tvede, M., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16309 · Cited by 51
Ng, S. C., Chan, F. K. L., & Chan, P. K. S. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30124-2 · Cited by 51
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria
Wüthrich, I., Pelzer, B. W., Khodamoradi, Y., & Vehreschild, M. J. G. T. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1911279 · Cited by 50
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light
Zhang, J., Wu, K.-H., Shi, C., & Li, G. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-01027-2 · Cited by 50
Vendrik, K. E. W., Terveer, E. M., Kuijper, E. J., Nooij, S., Boeije-Koppenol, E., Sanders, I. M. J. G., van Lingen, E., Verspaget, H. W., Berssenbrugge, E. K. L., Keller, J. J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30473-4 · Cited by 49
Luo, M., Xin, R., Hu, F.-R., Li, Y., Hu, S., & Bai, F. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.144 · Cited by 51
An enterococcal phage-derived enzyme suppresses graft-versus-host disease
Fujimoto, K., Hayashi, T., Yamamoto, M., Sato, N., Shimohigoshi, M., Miyaoka, D., Yokota, C., Watanabe, M., Hisaki, Y., Kamei, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07667-8 · Cited by 49
Schlechte, J., Skalosky, I., Geuking, M. B., & McDonald, B. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00539-2 · Cited by 47
Lv, Q., Li, Z., Sui, A., Yang, X., Han, Y., & Yao, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977187 · Cited by 48
Oliveira, R. A., & Pamer, E. G. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.002 · Cited by 51
Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
Yan, J., Yang, L., Ren, Q., Zhu, C., Du, H., Wang, Z., Qi, Y., Xian, X., & Chen, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1471273 · Cited by 52
Gao, Y., Tan, Y.-J., & Fang, J. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01026-w · Cited by 50
Segal, J. P., Mullish, B. H., Quraishi, M. N., Iqbal, T. H., Marchesi, J. R., & Sokol, H. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820946904 · Cited by 51
Improving Risk–Benefit in Faecal Transplantation through Microbiome Screening
Papanicolas, L. E., Gordon, D., Wesselingh, S. L., & Rogers, G. B. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2019.12.009 · Cited by 47
Minarti, I. B., Dzakiy, M. A., & Nilautama, D. (2023) · At-Tasyrih jurnal pendidikan dan hukum Islam · doi:10.55849/attasyrih.v8i2.151 · Cited by 46
Zhou, Y., Li, Y., Zhang, L., Wu, Z., Huang, Y., Yan, H., Zhong, J. S., Wang, L., Abdullah, H. M., & Wang, H. H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01319 · Cited by 46
Baunwall, S. M. D., Dahlerup, J. F., Engberg, J., Erikstrup, C., Helms, M., Juel, M. A., Kjeldsen, J., Nielsen, H. L., Nilsson, A. C., Rode, A. A., et al. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1922749 · Cited by 45
Wilcox, M. H., McGovern, B., & Hecht, G. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa114 · Cited by 47
Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans
Shtossel, O., Turjeman, S., Riumin, A., Goldberg, M. R., Elizur, A., Bekor, Y., Mor, H., Koren, O., & Louzoun, Y. (2023) · Microbiome · doi:10.1186/s40168-023-01623-w · Cited by 44
Munir, M. U., Ali, S. A., Chung, K. H. K., Käkinen, A., Javed, I., & Davis, T. P. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2422468 · Cited by 45
Shabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 48
Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis
Riwes, M. M., & Reddy, P. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.06.001 · Cited by 44
Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections
Mindt, B. C., & DiGiandomenico, A. (2022) · Antibiotics · doi:10.3390/antibiotics11040474 · Cited by 47
A decade of advances in human gut microbiome-derived biotherapeutics
Pribyl, A. L., Hugenholtz, P., & Cooper, M. A. (2025) · Nature Microbiology · doi:10.1038/s41564-024-01896-3 · Cited by 43
Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation
Čierniková, S., Kasperová, B. J., Drgoňa, Ľ., Smolková, B., Števurková, V., & Mego, M. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100790 · Cited by 43
Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections
Ducarmon, Q. R., Kuijper, E. J., & Olle, B. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa779 · Cited by 42
Poylin, V. Y., Hawkins, A. T., Bhama, A. R., Boutros, M., Lightner, A. L., Khanna, S., Paquette, I. M., & Feingold, D. L. (2021) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000002047 · Cited by 43
Innes, A. J., Mullish, B. H., Ghani, R., Szydlo, R., Apperley, J. F., Olavarría, E., Palanicawandar, R., Kanfer, E., Milojković, D., McDonald, J. A. K., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.684659 · Cited by 42
Antimicrobial resistance: new insights and therapeutic implications
Sheikh, B. A., Bhat, B. A., & Mir, M. A. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12175-8 · Cited by 42
The Evolving Landscape of Fecal Microbial Transplantation
Shao, T., Hsu, R., Hacein-Bey, C., Zhang, W., Gao, L., Kurth, M. J., Zhao, H., Shuai, Z., & Leung, P. S. C. (2023) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-023-08958-0 · Cited by 43
Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
Yue, X., Zhou, H., Wang, S., Chen, X., & Xiao, H. (2024) · Cancer Medicine · doi:10.1002/cam4.6799 · Cited by 45
Watkins, R., & Bonomo, R. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.04.002 · Cited by 42
Current status of fecal microbiota transplantation for irritable bowel syndrome
El‐Salhy, M., Hausken, T., & Hatlebakk, J. G. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14157 · Cited by 45
Ghani, R., Mullish, B. H., Roberts, L. A., Davies, F., & Marchesi, J. R. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2038856 · Cited by 43
Osman, M., Budree, S., Kelly, C. R., Panchal, P., Allegretti, J. R., Kassam, Z., Olesen, S. W., Ramakrishna, B., Dubois, N. E., OʼBrien, K., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.051 · Cited by 42
Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.03.001 · Cited by 42
Chen, C., Su, Q., Zi, M., Hua, X., & Zhang, Z. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00818-3 · Cited by 45
Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic
Kazemian, N., Kao, D. H., & Pakpour, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063004 · Cited by 41
Current and future applications of fecal microbiota transplantation for children
Chen, C.-C., & Chiu, C. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.11.004 · Cited by 41
Nee, J. W., & Lembo, A. J. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16625 · Cited by 41
The emerging potential ofmicrobiome transplantation on human health interventions
Junca, H., Pieper, D. H., & Medina, E. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.01.009 · Cited by 41
Gut microbiota and ionizing radiation-induced damage: Is there a link?
Yu, Y., Lin, X., Feng, F., Wei, Y., Wei, S., Gong, Y., Guo, C., Wang, Q., Shuai, P., Wang, T., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115947 · Cited by 40
Management of Clostridioides difficile infection in patients with inflammatory bowel disease
Khanna, S. (2020) · Intestinal Research · doi:10.5217/ir.2020.00045 · Cited by 41
García, A., & Fox, J. G. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-20-000054 · Cited by 46
Cui, J., Lin, Z., Tian, H., Yang, B. K., Zhao, D., Ye, C., Li, N., Qin, H., & Chen, Q. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.710452 · Cited by 40
Khan, R., Roy, N., Ali, H., & Naeem, M. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/9999925 · Cited by 41
Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome
Singh, P., & Lembo, A. J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.03.003 · Cited by 39
Valdez, B. S., Beltrán‐Partida, E., Zlatev, R. K., Stoytcheva, M., González-Mendoza, D., Salvador‐Carlos, J., Moreno‐Ulloa, A., & Cheng, N. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111501 · Cited by 41
Goeser, F., Sifft, B., Stein‐Thoeringer, C. K., Farowski, F., Strassburg, C. P., Brossart, P., Higgins, P. G., Scheid, C., Wolf, D. G. F., Holderried, T. A. W., et al. (2021) · European Journal Of Haematology · doi:10.1111/ejh.13642 · Cited by 39
Gut Microbiota Manipulation in Irritable Bowel Syndrome
Mazzawi, T. R. E. (2022) · Microorganisms · doi:10.3390/microorganisms10071332 · Cited by 40
Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
Aguirre, A. M., & Sorg, J. A. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2094672 · Cited by 41
Biliński, J., Lis, K., Tomaszewska, A., Grzesiowski, P., Dzieciątkowski, T., Tyszka, M., Karakulska‐Prystupiuk, E., Boguradzki, P., Tormanowska, M., Hałaburda, K., et al. (2020) · American Journal of Hematology · doi:10.1002/ajh.26077 · Cited by 38
Pession, A., Zama, D., Muratore, E., Leardini, D., Gori, D., Guaraldi, F., Prete, A., Turroni, S., Brigidi, P., & Masetti, R. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020100 · Cited by 38
Fecal microbiota transplantation for recurrent Clostridioides difficile , safety, and pitfalls
Sandhu, A., & Chopra, T. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211053105 · Cited by 38
Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea
Gweon, T., Lee, Y. J., Kim, K. O., Yim, S. K., Soh, J. S., Kim, S. Y., Park, J. J., Shin, S. Y., Lee, T. H., Choi, C. H., et al. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21221 · Cited by 38
Malard, F., Gaugler, B., & Mohty, M. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00223-x · Cited by 38
Ju, X., Jiang, Z., Ma, J., & Yang, D. J. (2024) · Nutrients · doi:10.3390/nu16111727 · Cited by 38
Metadata
- Authors
- DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L.
- Affiliations
- Harvard University (US)
- From the Blood and Marrow Transplant Program (Z.D., Y.-B.C.), the Liver Center, Division of Gastroenterology (P.P.B., R.T.C.), and the Division of Infectious Diseases (M.T.S., M.K.M., S.T., E.L.H.), Massachusetts General Hospital, Harvard Medical School (Z.D., P.P.B., M.T.S., M.K.M., S.T., R.T.C., Y.-B.C., E.L.H.), and Day Zero Diagnostics (M.R.A.S., M.H.H.) — all in Boston.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-11-21
- Volume
- 381
- Issue
- 21
- Pages
- 2043-2050
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2982566732
- Cited by
- 1,281
- References
- 26
- Citations by year
- 2026: 202 · 2025: 160 · 2024: 158 · 2023: 175 · 2022: 169 · 2021: 184 · 2020: 222 · 2019: 10
- FWCI
- 112.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- drug-resistant Escherichia coli, bacteremia, fecal microbiota transplantation, donor screening, genome sequencing
- MeSH terms
- Fecal Microbiota Transplantation, Aged, beta-Lactamases, Escherichia coli, Feces, Hepatic Encephalopathy, Humans, Male, Myelodysplastic Syndromes, Bacteremia, Fatal Outcome, Drug Resistance, Bacterial, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
